Medical Advocates
Efavirenz/Tenofovir/Emtricitabine (Atripla)
 
Main Page

New and Noteworthy
Journal Citations
Pediatric Updates
Product Information







 
ARV Drugs Main Page Main New/Newsworthy  Home Page      
This web page is best viewed by using INTERNET EXPLORER
Last Update:  August 05, 2011  
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
New and Noteworthy
     
July 2011
 
IAS 2011 Citations
 
  • POSTER
     Is atripla a feasible switch option in patients with an existing M184V mutation?
    N. Rockwood, M. Nelson, G. Jagjit Singh
    Poster     Abstract
Journal Citations
     
General Reports
 
 
Budget impact of a set-dose combination of efavirenz-emtricitabine-tenofovir in the treatment of
patients infected with HIV-1.
 Oyagüez I, Casado MA, Cotarelo M, et al.
 Farm Hosp. 2009 Sep 1;33(5):247-56
 Abstract

Efavirenz + emtricitabine + tenofovir: new combination. HIV infection: do not modify
ongoing therapy just to use one less tablet.
[No authors listed] 
Prescrire Int. 2009 Jun;18(101):105.
 Abstract

A WEEK IN REVIEW FEATURED REPORT
FULL-TEXT ARTICLE
Atripla - HIV therapy in one pill.
 Julg B, Bogner JR.   
 Ther Clin Risk Manag. 2008 Jun;4(3):573-7.
 Paper
 
A WEEK IN REVIEW FEATURED REPORT
Cost-effectiveness analysis of emtricitabine/tenofovir versus lamivudine/zidovudine, in
combination with efavirenz, in antiretroviral-naive, HIV-1-infected patients.
 Sánchez-de la Rosa R, Herrera L, Moreno S.
 Clin Ther. 2008 Feb;30(2):372-81.
 Abstract

A WEEK-IN-REVIEW FEATURED REPORT
The first once-daily single-tablet regimen for the treatment of HIV-infected patients.
 Killingley B, Pozniak A.  
 Drugs Today (Barc). 2007 Jul;43(7):427-42
 Abstract

Bioequivalence of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet
Regimen.
 Mathias AA, Hinkle J, Menning M, et al 
J Acquir Immune Defic Syndr. 2007 Jul 19;
 Abstract

Efavirenz/Emtricitabine/Tenofovir disoproxil fumarate: triple combination tablet.
 Frampton JE, Croom KF. 
Drugs. 2006;66(11):1501-12
 Abstract
 
A WEEK-IN-REVIEW FEATURED REPORT
 Tenofovir Disoproxil Fumarate, Emtricitabine, and Efavirenz Versus Fixed-Dose Zidovudine/
Lamivudine and Efavirenz in Antiretroviral-Naive Patients: Virologic, Immunologic, and
Morphologic Changes: A 96-Week Analysis.
 Pozniak AL, Gallant JE, Dejesus E, et al  
J Acquir Immune Defic Syndr. 2006 Oct 12;
 Abstract
 

Efficacy
 
 
Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen (Atripla®):
A Review of its Use in the Management of HIV Infection.
 Deeks ED, Perry CM
Drugs. 2010 Dec 3;70(17):2315-2338.
Abstract

Efavirenz + emtricitabine + tenofovir: new combination. HIV infection: do not modify
ongoing therapy just to use one less tablet.
 [No authors listed] 
Prescrire Int. 2009 Jun;18(101):105.
 Abstract

A WEEK-IN-REVIEW FEATURED REPORT
Simplification of Antiretroviral Therapy to a Single-Tablet Regimen Consisting of Efavirenz, Emtricitabine,
and Tenofovir Disoproxil Fumarate Versus Unmodified Antiretroviral Therapy in Virologically Suppressed
HIV-1-Infected Patients.
 Dejesus E, Young B, Morales-Ramirez JO, et al
J Acquir Immune Defic Syndr. 2009 Apr 7.
Abstract
 
FULL-TEXT ARTICLE
 Effectiveness and safety of generic fixed-dose combination of tenofovir/emtricitabine/efavirenz in HIV-1-infected
patients in Western India.
 Pujari S, Dravid A, Gupte N, et al 
Medscape J Med. 2008;10(8):196.
 Paper
Pediatric Data
 
USPHS Pediatric Antiretroviral Drug Information
 US Treatment Guidelines

ARV Drugs Main Page Main New/Newsworthy  Home Page      

Efavirenz/Emtricitabine/Tenofovir (Atripla)